Skip to main content
Sign In

In The News

Welcome to the Department of Neurology


Colorado Poet’s Brain To Be Used To Study Down Syndrome-Alzheimer’s Link

Gretchen Josephson’s family recently donated her brain to the CU School of Medicine. Huntington Potter, who discovered that the chromosomal abnormality seen in Down Syndrome is also found in people with Alzheimer’s disease, said Josephson’s brain will be used to help develop treatments for people with Alzheimer’s.

Colorado Public Radio, Oct. 4, 2017


Should You Take Vitamin B12 to Boost Mood?

“We know that B12 deficiency is very bad for the nervous system,” says Dr. Jonathan Woodcock, an associate professor of neurology and psychiatry at the CU School of Medicine.

U.S. News & World Report, Sept. 21, 2017


Experts Share Insights on New Developments in Tardive Dyskinesia

Dr. Lauren Seeberger, Associate Professor of Neurology at the CU School of Medicine and Director of the Movement Disorders Center at the University of Colorado Hospital: “The development of valbenazine and successful trial work leading to FDA approval to treat tardive dyskinesia is a breakthrough for these patients who have been treated empirically to date.”

MD Magazine, September 19, 2017


CO doctors find preliminary results ‘positive’ in early tests of Alzheimer’s drug

“Based on their starting place,” said Dr. Huntington Potter of the CU Anschutz Medical Campus, “people who received Leukine versus people who received the placebo, showed a difference in activities of daily living.”

9News, July 19, 2017


Can lasers heal brain injuries? Two Colorado docs shine a light.

“We don’t have an approved, accepted biological test that says you’ve had a concussion,” notes Dr. James Kelly, Professor of Neurology at the CU Anschutz Medical Campus. “We don’t have that on traumatic brain injury, either — especially at the mild end of the spectrum.”

Westword, July 4, 2017


CU Anschutz accepting applications for patients in new veteran services center

“People who have lingering concussion symptoms that simply haven’t resolved can come here no matter what else has been tried for this intensive care program,” said Dr. James Kelly, Executive Director of the Marcus Institute for Brain Health (MIBH), a new veteran services center on the University of Colorado Anschutz campus.

Channel 7, June 4, 2017


Your Healthy Family: UCHealth’s Mobile Stroke Unit

Dr. Williams Jones, Medical Director for UCHealth’s Mobile Stroke Program: “It's like bringing the emergency department to the patient, and in stroke care it’s very important to treat people as quickly as possible.”

KOAA-TV, May 25, 2017


New Hope for Alzheimer’s

Denver’s NBC affiliate, 9News/KUSA, produced a three-part series about Alzheimer’s disease research that includes interviews with researchers from the Rocky Mountain Alzheimer’s Disease Center and footage from Dr. Huntington Potter's Lab.

9News, May 2017

Zika virus can trigger epilepsy

Beyond its known links to birth defects and other problems, the Zika virus may also trigger cases of epilepsy in infants, warn experts from the U.S. Centers for Disease Control and Prevention, including Dr. Daniel Pastula, Assistant Professor of Neurology.

CBS News, April 18, 2017

What Can Sleep Patterns Tell Me About Possibly Having MS?

“It’s not only insomnia,” points out Enrique Alvarez, Assistant Professor of Neurology at the CU School of Medicine. “People with MS are affected by nocturnal leg spasms, restless leg syndrome, narcolepsy, REM sleep behavior disorder and sleep disordered breathing (apnea). Any one of these conditions can interfere with slumber and contribute to profound fatigue during waking hours.”
U.S. News & World Report, April 10, 2017

CU researcher Penny Clarke, PhD, secures CCTSI pilot grant to study Zika virus

Far from the tropical environs where Zika thrives, researchers at the University of Colorado Anschutz Medical campus are investigating how exactly the virus causes damage to the central nervous system (CNS). To help do this groundbreaking work, the Colorado Clinical and Translational Sciences Institute has awarded Neurology Professor Penny Clarke a pilot grant for her translational neuroscience research.

Colorado Clinical and Translational Sciences Institute, March 23, 2017



Can Some MS Patients Safely Stop Taking Medicines?

Neurologist John Corboy of the University of Colorado says patients constantly ask, “‘Hey doc, how long do I need to take this?’ We really have very little data to answer a very common question.”

PCORI Blog, March 5, 2017


A promising new treatment for Alzheimer’s

“We found so far that Leukine is safe in people with Alzheimer’s disease,” said Huntington Potter, the director of Alzheimer’s research at CU Anschutz. “That means that it doesn’t have the side effects that so many other Alzheimer’s drugs have had, which are swelling in the brain and bleeding into the brain.”

9News, February 28, 2017


A promising new treatment for Alzheimer’s

Timothy Boyd, a member of Potter’s research team, showed us a picture of a mouse brain with the tell-tale amyloid deposits. The left side of the brain has far fewer deposits than the right after only one injection of Leukine. “In seven days, that one injection removed about half the plaque -- all these little white spots -- from that side of the brain versus this side of the brain. It gets rid of them. We don’t know the exact mechanism.”

9News, February 28, 2017


A promising new treatment for Alzheimer’s

“When we target amyloid in the brain, when it is removed by these different drugs … the removal sometimes triggers changes in the brain such as small hemorrhages or swelling or edema in the brain which can result in quite a bit of cognitive difficulty,” said Jonathan Woodcock, who is the clinical director of the University of Colorado Hospital’s Memory Disorders Clinic.

9News, February 28, 2017


Progress in the fight against Alzheimer’s

CU’s First Lady Marcy Benson, whose mother battled Alzheimer’s: “I guess what I want people to understand is that it’s not just the children of people with Alzheimer’s that have a chance of getting it. As Dr. Potter says, ‘We all have a 50-50 chance of getting Alzheimer’s.’ I think everyone needs to be concerned about this, pay attention to it, give money when they can. It’s something that’s going to affect all of us, either as a caregiver or as someone with the disease.”

9News, February 27, 2017


Science closing in on polio-like virus that paralyzed children

“A lot of people were dubious about Enterovirus D68 because they said, ‘Gosh, this virus isn’t known to be neurotropic and we’re not finding it in the spinal fluid,’” said Kenneth Tyler, a CU neurologist and senior author of the paper. “We asked, ‘Would these (strains) produce a neurologic disease in mice, and would it be similar to what we saw in humans?’ And the answer was a resounding yes.”

University of Colorado School of Medicine, February 23, 2017
San Francisco Chronicle, February 26, 2017


Health Myths, Busted!

Multiple sclerosis is diagnosed more in Colorado than in other states. Yes. That’s not to say location explains causation. Not exactly, anyway. “It’s the distance from the equator that’s associated with high risk,” says John Corboy, co-director of the Rocky Mountain Multiple Sclerosis Center at the CU Anschutz Medical Campus.

5280, January 2017


4 Healthy Habits to Adopt

No specific diet has been proven to help MS patients, but a well-rounded plan such as the Mediterranean diet, has been associated with a lower risk of cognitive decline, heart disease, and diabetes, says John Corboy, professor of neurology at the CU School of Medicine and co-director of the Rocky Mountain Multiple Sclerosis Center at Anschutz Medical Campus.

Neurology Now, Jan. 17, 2017


CO doctors find preliminary results ‘positive’ in early tests of Alzheimer’s drug

“Based on their starting place,” said Dr. Huntington Potter of the CU Anschutz Medical Campus, “people who received Leukine versus people who received the placebo, showed a difference in activities of daily living.”

9News, July 19, 2017


Should older MS patients stop taking certain treatments? CU Anschutz Medical Campus will expand its study

John Corboy, professor of neurology and co-director of the Rocky Mountain MS Center at CU Anschutz: “It’s fairly clear that these medicines give the greatest benefit to people when they are younger.”

Denverite, Nov. 2, 2016


Gary Kubiak diagnosed with “complex migraine,” will not coach Thursday in San Diego

“A lot of people know about migraines that cause visual changes or flashing lights in the eyes or some loss of vision, like a blind spot. But migraines can also cause symptoms that look more like a stroke,” said Sharon Poisson, a neurologist at University of Colorado Hospital.

Denver Post, October 10, 2016

A mysterious polio-like illness that paralyzes people may be surging this year

“We are definitely hearing of cases from our colleagues across the country,” said Teri Schreiner, a neurologist at the University of Colorado and Children’s Hospital Colorado. “It’s a trend that’s worrisome … what I’m hearing from others seems to be coming at a tempo similar to what happened in 2014.”


​One glimmer of good news came from Kenneth Tyler, chair of neurology at the CU School of Medicine: “It looks like we’re seeing protection with IVIG in the mouse model.”



Washington Post, Sept. 21, 2016


In Memoriam: Don Gilden, MD  |  1937-2016

Dr. Donald Gilden, the Department of Neurology's second and longest serving Chair (1985-2009), passed away after a long illness on August 22, 2016. Dr. Gilden came to Colorado to lead the School of Medicine's Department of Neurology in 1985 and remained an active member of the faculty until his death. Don was an undergraduate at Dartmouth, received his Medical degree from the University of Maryland, and then trained in Neurology at the University of Chicago. He was a Professor of Neurology at the Wistar Institute and the University of Pennsylvania when he was recruited in 1985 to become the second Chair of the University of Colorado's Department of Neurology. Read more...

Department of Neurology, Aug. 23, 2016


Colorado researcher gets $1 million to advance Alzheimer’s drug trial

Researcher Huntington Potter, director of the Rocky Mountain Alzheimer’s Disease Center and a University of Colorado professor, has been awarded $1 million to advance his clinical trial that focuses on treating neuroinflammation to slow or halt the disease.

Denver Post, Aug. 4, 2016


William Jones, MD

Mobile Stroke Treatment Unit comes to Colorado Springs

“The highly-trained stroke teams at hospitals throughout UCHealth are focused on providing life-saving treatments to stroke patients as quickly as possible,” said Dr. William Jones, medical director of stroke services for UCHealth. “Until now, we’ve had to wait until a patient arrives at the hospital to treat them. Now, our teams are able to actually examine a patient and start treatment before they even arrive at the emergency department.”

August 4, 2016


UCHealth testing device for chronic migraines

The University of Colorado Hospital’s Lowry Clinic is the first in the country to conduct clinical trials of a non-invasive device that treats chronic migraines. Marius Birlea, a neurologist with the CU School of Medicine, is leading the trial that began in January. Birlea directs the Headache Clinic at University of Colorado Hospital.

9News, July 22, 2016


The Power of Faith

Douglas Ney, a neuro-oncologist with the University of Colorado Hospital who specializes in Erdheim-Chester disease: “When people approach this with a good support — either in their faith or outlook — the time that they have really becomes of quality.”

Lakewood Sentinel, June 27, 2016


CU researchers find key to some symptoms of severe West Nile infection

A study by Kenneth Tyler and Bette K. DeMasters of the CU School of Medicine, in collaboration with Washington University in St. Louis, has unlocked the cause of memory loss, mood disorders and other symptoms triggered by severe cases of West Nile virus, an illness spread by mosquitoes that affected more than 100 Coloradans last year and led to two deaths.
“It helps us understand the mechanisms for something we’ve been seeing in patients,” said Kenneth Tyler, chairman of the neurology department on CU’s Anschutz Medical Campus. “They’re things we actually have drugs for, that are being used in other situations, that may block some of the bad effects of these pathways.”

Denver Post, June 22, 2016


Colorado woman infected with Zika on trip to Mexico

“Colorado’s climate is a little too cold and we are a little too far north for the normal habitat of the mosquitos that transmit Zika,” said Ken Tyler, who studies the virus at the CU School of Medicine. “Zika is usually a pretty mild infection. So the real concern has been in the risk to pregnant women.”

9News, June 22, 2016


Preparation remains the best Alzheimer’s defense

Every 66 seconds someone is diagnosed with Alzheimer's disease. In the battle between science and disease, Alzheimer's has been the clear winner for decades. There has not been a new drug approved to treat the disease since 2003. "This is a very common disease in the elderly,”Dr. Woodcocknotes. “It's important for everyone to plan for the possibility because the older we live the more likely we are going to get dementia at some point. Making plans ahead of time makes sense.” Lifestyle changes and advance care planning are first and second lines of defense.

Source: UCHealth Today, June 7, 2016


Spirit, attitude help stroke patient battle back from the brink at UCH

The diagnosis and treatment of a patient with a severe stroke involved collaboration among a team of University of Colorado Hospital physicians, among them Sharon Poisson, MD, Co-Medical Director of the Stroke Program at UCH. Jim Cohen continues to drive himself on a long road to recovery, assisted by family and providers.

Source: UCHealth Today, June 7, 2016


Doctors researching Zika ahead of Olympics

Ken Tyler, a neurologist with the University of Colorado Hospital and department chair of Neurology at the CU School of Medicine: “The more people you have going to and coming back from areas where there’s infection, the more likelihood you have of establishing disease in the United States.”

9News, May 29, 2016


Tracking the Rise of Zika Complications

“This is the first time, in the last year or two, that Zika virus has spread to thousands and thousands of people throughout South America, Central America, Mexico, and the Caribbean, as well as other places in the Pacific,” said Daniel M. Pastula, neurologist and medical epidemiologist at the CU School of Medicine.

Medscape Multispecialty, May 27, 2016


MS Society: Progressive MS Biggest Challenge For Researchers

University of Colorado neurologist John Corboy, who is a board member for the National MS Socity Colorado/Wyoming Chapter: “I’m hopeful we will be reading about MS in the history books. Right now, we’ve made incredible leaps forward.”
CBS4, May 27, 2016